Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2007 Feb 22:6:8.
doi: 10.1186/1475-2840-6-8.

Pro-oxidant effect of alpha-tocopherol in patients with type 2 diabetes after an oral glucose tolerance test--a randomised controlled trial

Affiliations
Randomized Controlled Trial

Pro-oxidant effect of alpha-tocopherol in patients with type 2 diabetes after an oral glucose tolerance test--a randomised controlled trial

Mark S Winterbone et al. Cardiovasc Diabetol. .

Abstract

Background: As a part of a larger study investigating the effects of alpha-tocopherol on gene expression in type 2 diabetics we observed a pro-oxidant effect of alpha-tocopherol which we believe may be useful in interpreting outcomes of large intervention trials of alpha-tocopherol.

Methods: 19 type 2 diabetes subjects were randomised into two groups taking either 1200 IU/day of alpha-tocopherol or a matched placebo for 4 weeks. On day 0 and 29 of this study oxidative DNA damage was assessed in mononuclear cells from fasted blood samples and following a 2 h glucose tolerance test (GTT).

Results: On day 0 there was no significant difference in oxidative DNA damage between the two groups or following a GTT. On day 29 there was no significant difference in oxidative DNA damage in fasted blood samples, however following a GTT there was a significant increase in oxidative DNA damage in the alpha-tocopherol treatment group.

Conclusion: High dose supplementation with alpha-tocopherol primes mononuclear cells from patients with type 2 diabetes for a potentially damaging response to acute hyperglycaemia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Change in oxidative DNA damage, assessed by 8-oxoguanine fluorescence, in mononuclear cells isolated from type 2 diabetes patients before (GTT1) and after (GTT2) taking 1200 IU/day α-tocopherol or matched placebo for 4 weeks, following a glucose tolerance test. Data shown are means; error bars represent 95% confidence intervals. AT: α-tocopherol, GTT: Glucose Tolerance Test

References

    1. Jay D, Hitomi H, Griendling KK. Oxidative stress and diabetic cardiovascular complications. Free Radical Biology and Medicine. 2006;40:183–192. doi: 10.1016/j.freeradbiomed.2005.06.018. - DOI - PubMed
    1. Sampson MJ, Gopaul N, Davies IR, Hughes DA, Carrier MJ. Plasma F2 Isoprostanes: Direct evidence of increased free radical damage during acute hyperglycemia in type 2 diabetes. Diabetes Care. 2002;25:537–541. - PubMed
    1. M.J S, S A, S R, G W, I.R D, DA H, S S. Increased DNA oxidative susceptibility without increased plasma LDL oxidizability in Type II diabetes: effects of a-tocopherol supplementation. Clinical Science. 2001;101:235–241. doi: 10.1042/CS20010112. - DOI - PubMed
    1. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicotera T. Oxidative damage to DNA in diabetes mellitus. The Lancet. 1996;347:444–445. doi: 10.1016/S0140-6736(96)90013-6. - DOI - PubMed
    1. Sampson MJ, Winterbone MS, Hughes JC, Dozio N, Hughes DA. Monocyte Telomere Shortening and Oxidative DNA Damage in Type 2 Diabetes. Diabetes Care. 2006;29:283–289. doi: 10.2337/diacare.29.02.06.dc05-1715. - DOI - PubMed

Publication types

MeSH terms